RALEIGH, N.C., March 9 /PRNewswire/ -- Arbor Pharmaceuticals ("Arbor"), a specialty pharmaceutical company focused exclusively on pediatric medicine, announced today that the company has launched Pediaderm(TM) HC Complete Kit - an innovative new product for the comprehensive management of atopic dermatitis. Pediaderm HC Complete Kit contains Pediaderm HC (Hydrocortisone Lotion USP 2%) and patented Pediaderm Protective Emollient with Triple Synergy Technology(TM). Pediaderm HC Complete Kit has been specifically developed to treat, manage, and protect the skin of children with atopic dermatitis, commonly referred to as eczema.
"Arbor is excited to introduce this novel and comprehensive approach to the treatment and management of atopic dermatitis for children suffering from this troubling disease. The patented Triple Synergy Technology contained within the Pediaderm Protective Emollient is a unique technology that provides an innovative approach to treating AD. As a pediatric pharmaceutical company our mission is to introduce novel products that offer better solutions for the most common childhood illnesses. Pediaderm HC Complete Kit represents another important step for the company in fulfilling that mission," stated Jarrett Disbrow, President and CEO of Arbor Pharmaceuticals.
Pediaderm HC Complete Kit is available by prescription only at retail pharmacies across the U.S. Pediaderm HC Complete Kit is directly promoted to U.S. pediatricians by Arbor Pharmaceuticals' specialty sales force. Pediaderm HC Complete Kit is Arbor Pharmaceuticals' fourth product launch since the company initiated commercial operations less than two years ago.
Pediaderm HC Lotion
Pediaderm HC Lotion is for topical use only and should not be used ophthalmically.
Pediaderm Protective Emollient
Pediaderm Protective Emollient is nonsteroidal and is intended for topical use only.
About Arbor Pharmaceuticals
Arbor Pharmaceuticals, headquartered in Raleigh, North Carolina, is a specialty pharmaceutical company focused exclusively on the growing pediatric market. The company intends to become the leading pediatrics-focused pharmaceutical company by actively licensing, developing and commercializing late-stage products for significant pediatric conditions. In addition to PEDIADERM(TM) HC COMPLETE KIT, Arbor also currently markets three nonantibiotic products for varying otic conditions including XYLAREX(R), ZINOTIC(R) and NEOTIC(R).
See www.pediaderm.com for full prescribing information.
Xylarex, Zinotic, and Neotic are registered trademarks of Arbor Pharmaceuticals, Inc.
CONTACT: Jarrett Disbrow, President and Chief Executive Officer of Arbor
Pharmaceuticals, Inc., +1-919-792-1701
Web site: http://www.arborpharma.com/
